Portfolio - 23andMe
Developer of consumer genetic research technology designed to help people access, understand and benefit from the human genome. The company’s platform offers gene indexing while highlighting significant findings through web-based interactive tools, enabling patients to gain insights into personal ancestry, genealogy, and inherited traits. 23andMe is the first and only direct-to-consumer DNA test that includes 55+ health reports that meet FDA requirements. Source: PitchBook.
Visit 23andMe Website
999 Canada Place Suite 654
Vancouver, BC V6C 3E1
19 Fulton St. Suite #307
New York, NY 10038, USA
Securities products and services are offered by InvestX Markets LLC, member of
and InvestX Financial (Canada) Ltd., a registered exempt market dealer in the provinces of British Columbia, Alberta, Ontario, Quebec and New Brunswick. © 2023 All Rights Reserved.